Brind.

Vale and Aperam Compared on Financial Metrics and Market Valuation

1 report, 1 independent Updated Oct 6
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Vale and Aperam are materials companies that are currently competing for investment opportunities. An independent report compares the two companies across several financial metrics, including revenue, earnings per share, and valuation. The report notes that Vale has higher revenue and earnings than Aperam, while Aperam is trading at a lower price-to-earnings ratio, suggesting it is currently more affordable of the two stocks.

From dailypolitical.com

Why it matters

Some supportBrind's analysis of the reports

The comparison highlights differences in operational profiles, risk exposure, and shareholder returns. Vale has a beta of 0.42, indicating lower share price volatility compared to Aperam's beta of 1.34. Regarding dividends, Vale pays an annual dividend of $0.44 per share, while Aperam pays $1.96 per share.

From dailypolitical.com

Who's involved

  • ValeMultinational diversified metals and mining corporation
  • AperamCompany in the materials sector

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped